In this Quick Take volume, our expert faculty examine timely research on electroconvulsive therapy as an effective adjunct for clozapine in the treatment of ultra treatment-resistant schizophrenia, trazodone as a possible first-line treatment for insomnia, and Silexan s potential benefits for alleviating neuropsychiatric symptoms associated with post-COVID syndrome. Our faculty also discuss studies on medication risks, such as antipsychotic drugs and the risk for acute pancreatitis as well as benzodiazepines and the risk for suicide attempt.
- Provider:Medical Academy, LLC
- Activity Link: https://psychopharmacologyinstitute.com/publication/quick-take-vol-57-2776?utm_source=MAwebsite&utm_medium=MAwebsite&utm_campaign=MAwebsite
- Start Date: 2023-12-01 06:00:00
- End Date: 2023-12-01 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Knowledge, Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest